Bain Capital to Buy Mitsubishi Chemical's Pharma Business for More Than $3 Billion — Update
Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.
Mitsubishi Chemical sells pharmaceuticals subsidiary to Bain in $3.36 billion deal
Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...
process-worldwide.com1d
Mitsubishi Gas Chemical to Develop H2 Solutions by Methanol Reforming Technology
Mitsubishi Gas Chemical has partnered with Methanol Reformer and Element 1 Corp. to develop as well as commercialize hydrogen ...
Organic Titanate Market is Projected to Grow at 7.1% CAGR, Reaching US$ 1,770.8 Million by 2034 | Fact.MR Report
Sustainable Innovation Drives Growth in Organic Titanate Market, Transforming Automotive, Electronics, and Coatings Industries with High-Performance SolutionsRockville, MD , Feb. 06, 2025 (GLOBE ...
The Magazine3d
Mitsubishi Gas Chemical to partner with Methanol Reformer S.L. and Element 1 Corp. related to methanol-to-hydrogen technologies
Methanol Reformer S.L., a Spanish leader in Methanol-to-Hydrogen generator manufacturing, and Element 1 Corp., a ...
Mitsubishi Gas Chemical Company, Inc., Methanol Reformer S.L., and Element 1® Corp. Announce Strategic Collaboration
Mitsubishi Gas Chemical Company, Inc. (MGC), a Japanese methanol manufacturer and supplier for chemical and energy sectors including Methanol-to-Hydrogen applications, Methanol Reformer S.L., a ...